Skip to main content
Erschienen in: Diabetologia 12/2010

01.12.2010 | Article

Short-term hyperglycaemia causes non-reversible changes in arterial gene expression in a fully ‘switchable’ in vivo mouse model of diabetes

verfasst von: S. Zervou, Y.-F. Wang, A. Laiho, A. Gyenesei, L. Kytömäki, R. Hermann, S. Abouna, D. Epstein, S. Pelengaris, M. Khan

Erschienen in: Diabetologia | Ausgabe 12/2010

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

Irreversible arterial damage due to early effects of hypo- or hyperglycaemia could account for the limited success of glucose-lowering treatments in preventing cardiovascular disease (CVD) events. We hypothesised that even brief hypo- or hyperglycaemia could adversely affect arterial gene expression and that these changes, moreover, might not be fully reversible.

Methods

By controlled activation of a ‘switchable’ c-Myc transgene in beta cells, adult pIns-c-MycERTAM mice were rendered transiently hypo- and then hyperglycaemic, after which they were allowed to recover for up to 3 months. Immediate and sequential changes in aortic global gene expression from normal glycaemia through hypo- and hyperglycaemia to recovery were assessed.

Results

Gene expression was compared with that of normoglycaemic transgenic and tamoxifen-treated wild-type controls. Overall, expression of 95 genes was significantly affected by moderate hypoglycaemia (glucose down to 2.5 mmol/l), whereas over 769 genes were affected by hyperglycaemia. Genes and pathways activated included several involved in atherogenic processes, such as inflammation and arterial calcification. Although expression of many genes recovered to initial pre-exposure levels when hyperglycaemia was corrected (74.9%), in one in four genes this did not occur. Quantitative reverse transcriptase PCR and immunohistochemistry verified the gene expression patterns of key molecules, as shown by global gene arrays.

Conclusions/interpretation

Short-term exposure to hyperglycaemia can cause deleterious and persistent changes in arterial gene expression in vivo. Brief hypoglycaemia also adversely affects gene expression, although less substantially. Together, these results suggest that early correction of hyperglycaemia and avoidance of hypoglycaemia may both be necessary to avoid excess CVD risk in diabetes.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of longer complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977–986CrossRef The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of longer complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977–986CrossRef
2.
Zurück zum Zitat UK Prospective Diabetes Study (UKPDS) (1998) Group intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet 352:837–853CrossRef UK Prospective Diabetes Study (UKPDS) (1998) Group intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet 352:837–853CrossRef
3.
Zurück zum Zitat Haffner SM, D'Agostino R Jr, Festa A et al (2003) Low insulin sensitivity (S(i) = 0) in diabetic and nondiabetic subjects in the insulin resistance atherosclerosis study: is it associated with components of the metabolic syndrome and non-traditional risk factors? Diabetes Care 26:2796–2803CrossRefPubMed Haffner SM, D'Agostino R Jr, Festa A et al (2003) Low insulin sensitivity (S(i) = 0) in diabetic and nondiabetic subjects in the insulin resistance atherosclerosis study: is it associated with components of the metabolic syndrome and non-traditional risk factors? Diabetes Care 26:2796–2803CrossRefPubMed
4.
Zurück zum Zitat Milicevic Z, Raz I, Beattie SD, Campaigne BN, Sarwat S, Gromniak E (2008) Natural history of cardiovascular disease in patients with diabetes. Diabetes Care 31:S155–S160CrossRefPubMed Milicevic Z, Raz I, Beattie SD, Campaigne BN, Sarwat S, Gromniak E (2008) Natural history of cardiovascular disease in patients with diabetes. Diabetes Care 31:S155–S160CrossRefPubMed
5.
Zurück zum Zitat The ADVANCE Collaborative Group (2008) Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. New Engl J Med 358:2560–2572CrossRef The ADVANCE Collaborative Group (2008) Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. New Engl J Med 358:2560–2572CrossRef
6.
Zurück zum Zitat Wei M, Gaskill SP, Haffner S, Stern MP (1998) Effects of diabetes and level of glycaemia on all-cause and cardiovascular mortality. The San Antonio Heart Study. Diabetes Care 21:1167–1172CrossRefPubMed Wei M, Gaskill SP, Haffner S, Stern MP (1998) Effects of diabetes and level of glycaemia on all-cause and cardiovascular mortality. The San Antonio Heart Study. Diabetes Care 21:1167–1172CrossRefPubMed
7.
Zurück zum Zitat Meigs JB, D’Agostino RB Sr, Nathan DM, Rifai N, Willson PW, Framingham Offspring Study (2002) Longitudinal association of glycaemia and microalbuminuria: the Framingham Offspring Study. Diabetes Care 25:977–983CrossRefPubMed Meigs JB, D’Agostino RB Sr, Nathan DM, Rifai N, Willson PW, Framingham Offspring Study (2002) Longitudinal association of glycaemia and microalbuminuria: the Framingham Offspring Study. Diabetes Care 25:977–983CrossRefPubMed
8.
Zurück zum Zitat Middelbeek RJ, Horton ES (2007) The role of glucose as an independent cardiovascular risk factor. Current Diabetes Rep 7:43–49CrossRef Middelbeek RJ, Horton ES (2007) The role of glucose as an independent cardiovascular risk factor. Current Diabetes Rep 7:43–49CrossRef
9.
Zurück zum Zitat Rijkelijkhuizen JM, Nijpels G, Heine RJ, Bouter LM, Stehouwer CD, Dekekr JM (2007) High risk of cardiovascular mortality in individuals with impaired fasting glucose is explained by conversion to diabetes: the Hoorn study. Diabetes Care 30:332–336CrossRefPubMed Rijkelijkhuizen JM, Nijpels G, Heine RJ, Bouter LM, Stehouwer CD, Dekekr JM (2007) High risk of cardiovascular mortality in individuals with impaired fasting glucose is explained by conversion to diabetes: the Hoorn study. Diabetes Care 30:332–336CrossRefPubMed
10.
Zurück zum Zitat Juutilainen A, Lehto S, Rönnemaa T, Pyörälä K, Laakso M (2008) Similarity of the impact of type 1 and type 2 diabetes on cardiovascular mortality in middle-aged subjects. Diabetes Care 31:714–719CrossRefPubMed Juutilainen A, Lehto S, Rönnemaa T, Pyörälä K, Laakso M (2008) Similarity of the impact of type 1 and type 2 diabetes on cardiovascular mortality in middle-aged subjects. Diabetes Care 31:714–719CrossRefPubMed
11.
Zurück zum Zitat Home PD, Pocock SJ, Beck-Nielsen H et al (2005) Rosiglitazone evaluated for cardiac outcomes and regulation of glycaemia in diabetes (RECORD): study design and protocol. Diabetologia 48:1726–1735CrossRefPubMed Home PD, Pocock SJ, Beck-Nielsen H et al (2005) Rosiglitazone evaluated for cardiac outcomes and regulation of glycaemia in diabetes (RECORD): study design and protocol. Diabetologia 48:1726–1735CrossRefPubMed
12.
Zurück zum Zitat Nissen SE, Wolski K (2007) Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N Engl J Med 356:2457–2471CrossRefPubMed Nissen SE, Wolski K (2007) Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N Engl J Med 356:2457–2471CrossRefPubMed
13.
Zurück zum Zitat Donnini D, Del Terra E, Ambesi-Impiombato FS, Gurcio F (2003) New in vitro model to study high glucose-dependent endothelial dysfunctions. Biochimie 85:701–705CrossRefPubMed Donnini D, Del Terra E, Ambesi-Impiombato FS, Gurcio F (2003) New in vitro model to study high glucose-dependent endothelial dysfunctions. Biochimie 85:701–705CrossRefPubMed
14.
Zurück zum Zitat Otsuka A, Azuma K, Iesaki T et al (2005) Temporary hyperglycaemia provokes monocyte adhesion to endothelial cells in rat thoracic aorta. Diabetologia 48:2667–2674CrossRefPubMed Otsuka A, Azuma K, Iesaki T et al (2005) Temporary hyperglycaemia provokes monocyte adhesion to endothelial cells in rat thoracic aorta. Diabetologia 48:2667–2674CrossRefPubMed
15.
Zurück zum Zitat Quagliaro L, Piconi L, Asaloni R et al (2005) Intermittent high glucose enhances ICAM-1, VCAM-1 and E-selectin expression in human umbilical vein endothelial cells in culture: the distinct role of protein kinase C and mitochondrial superoxide production. Atherosclerosis 183:259–267CrossRefPubMed Quagliaro L, Piconi L, Asaloni R et al (2005) Intermittent high glucose enhances ICAM-1, VCAM-1 and E-selectin expression in human umbilical vein endothelial cells in culture: the distinct role of protein kinase C and mitochondrial superoxide production. Atherosclerosis 183:259–267CrossRefPubMed
16.
Zurück zum Zitat Christ M, Bauersachs J, Liebetrau C, Heck C, Gunther A, Wehling M (2002) Glucose increases endothelial-dependent superoxide formation in coronary arteries by NAD(P)H oxidase activation: attenuation by the 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor atorvastatin. Diabetes 51:2648–2652CrossRefPubMed Christ M, Bauersachs J, Liebetrau C, Heck C, Gunther A, Wehling M (2002) Glucose increases endothelial-dependent superoxide formation in coronary arteries by NAD(P)H oxidase activation: attenuation by the 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor atorvastatin. Diabetes 51:2648–2652CrossRefPubMed
17.
Zurück zum Zitat Garcia Soriano F, Viraq L, Jagtap P, Szabo et al (2001) Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation. Nat Med 7:108–113CrossRefPubMed Garcia Soriano F, Viraq L, Jagtap P, Szabo et al (2001) Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation. Nat Med 7:108–113CrossRefPubMed
18.
Zurück zum Zitat Kunlathoor VV, Wilson DL, LeBoeuf RC (1996) Increased atherosclerosis in streptozotocin-induced diabetic mice. J Clin Invest 97:1767–1773CrossRef Kunlathoor VV, Wilson DL, LeBoeuf RC (1996) Increased atherosclerosis in streptozotocin-induced diabetic mice. J Clin Invest 97:1767–1773CrossRef
19.
Zurück zum Zitat Renard C, Van Obberghen E (2006) Role of diabetes in atherosclerotic pathogenesis. What have we learned from animal models? Diabetes Metabol 32:15–29CrossRef Renard C, Van Obberghen E (2006) Role of diabetes in atherosclerotic pathogenesis. What have we learned from animal models? Diabetes Metabol 32:15–29CrossRef
20.
Zurück zum Zitat Wendt T, Haria E, Bucciarelli L et al (2006) RAGE modulates vascular inflammation and atherosclerosis in a murine model of type 2 diabetes. Atherosclerosis 185:70–77CrossRefPubMed Wendt T, Haria E, Bucciarelli L et al (2006) RAGE modulates vascular inflammation and atherosclerosis in a murine model of type 2 diabetes. Atherosclerosis 185:70–77CrossRefPubMed
21.
Zurück zum Zitat Goldberg IJ, Dansky HM (2006) Diabetic vascular disease: an experimental objective. Atheroscler Thromb Vasc Biol 26:1693–1701CrossRef Goldberg IJ, Dansky HM (2006) Diabetic vascular disease: an experimental objective. Atheroscler Thromb Vasc Biol 26:1693–1701CrossRef
22.
Zurück zum Zitat Werstuck GH, Khan MI, Femia G et al (2006) Glucosamine-induced endoplasmic reticulum dysfunction is associated with accelerated atherosclerosis in a hyperglycemic mouse model. Diabetes 55:93–101CrossRefPubMed Werstuck GH, Khan MI, Femia G et al (2006) Glucosamine-induced endoplasmic reticulum dysfunction is associated with accelerated atherosclerosis in a hyperglycemic mouse model. Diabetes 55:93–101CrossRefPubMed
23.
Zurück zum Zitat Tochino Y (1987) The NOD mouse as a model of type I diabetes. Crit Rev Immunol 8:49–81PubMed Tochino Y (1987) The NOD mouse as a model of type I diabetes. Crit Rev Immunol 8:49–81PubMed
24.
Zurück zum Zitat Bailey CJ, Flatt PR (1987) Increased responsiveness to glucoregulatory effect of opiates in obese-diabetic ob/ob mice. Diabetologia 30:33–37CrossRefPubMed Bailey CJ, Flatt PR (1987) Increased responsiveness to glucoregulatory effect of opiates in obese-diabetic ob/ob mice. Diabetologia 30:33–37CrossRefPubMed
25.
26.
Zurück zum Zitat Pelengaris S, Littlewood T, Khan M, Elia G, Evan G (1999) Reversible activation of c-Myc in skin: induction of a complex neoplastic phenotype by a single oncogenic lesion. Mol Cell 3:565–577CrossRefPubMed Pelengaris S, Littlewood T, Khan M, Elia G, Evan G (1999) Reversible activation of c-Myc in skin: induction of a complex neoplastic phenotype by a single oncogenic lesion. Mol Cell 3:565–577CrossRefPubMed
27.
Zurück zum Zitat Pelengaris S, Khan M, Evan G (2002) Suppression of Myc-induced apoptosis in beta cells exposes multiple innate oncogenic properties of Myc sufficient to trigger immediate carcinogenic progression. Cell 109:321–334CrossRefPubMed Pelengaris S, Khan M, Evan G (2002) Suppression of Myc-induced apoptosis in beta cells exposes multiple innate oncogenic properties of Myc sufficient to trigger immediate carcinogenic progression. Cell 109:321–334CrossRefPubMed
28.
Zurück zum Zitat Desouza C, Salazar H, Cheong B, Murgo J, Fonseca V (2003) Association of hypoglycaemia and cardiac ischemia A study based on continuous monitoring. Diabetes Care 26:1485–1489CrossRefPubMed Desouza C, Salazar H, Cheong B, Murgo J, Fonseca V (2003) Association of hypoglycaemia and cardiac ischemia A study based on continuous monitoring. Diabetes Care 26:1485–1489CrossRefPubMed
29.
Zurück zum Zitat Bonds DE, Miller ME, Bergenstal RM et al (2010) The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study. BMJ 340:b4909CrossRefPubMed Bonds DE, Miller ME, Bergenstal RM et al (2010) The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study. BMJ 340:b4909CrossRefPubMed
30.
Zurück zum Zitat Karteris E, Zervou S, Pang Y et al (2006) Progesterone signaling in human myometrium through two novel membrane G protein-coupled receptors: potential role in functional progesterone withdrawal at term. Mol Endocrinol 20:1519–1534CrossRefPubMed Karteris E, Zervou S, Pang Y et al (2006) Progesterone signaling in human myometrium through two novel membrane G protein-coupled receptors: potential role in functional progesterone withdrawal at term. Mol Endocrinol 20:1519–1534CrossRefPubMed
31.
Zurück zum Zitat Wu Z, Irizarry RA (2004) Preprocessing of oligonucleotide array data. Nat Biotech 22:656–658CrossRef Wu Z, Irizarry RA (2004) Preprocessing of oligonucleotide array data. Nat Biotech 22:656–658CrossRef
32.
Zurück zum Zitat Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the \( {2^{ - \Delta \Delta Ct}} \) method. Methods 25:402–408CrossRefPubMed Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the \( {2^{ - \Delta \Delta Ct}} \) method. Methods 25:402–408CrossRefPubMed
33.
Zurück zum Zitat Pascal SM, Guiot Y, Khan PS, Jonas JC M (2008) Effects of c-MYC activation on glucose stimulus-secretion coupling events in mouse pancreatic islets. Am J Physiol Endocrinol Metab 295:E92–E102CrossRefPubMed Pascal SM, Guiot Y, Khan PS, Jonas JC M (2008) Effects of c-MYC activation on glucose stimulus-secretion coupling events in mouse pancreatic islets. Am J Physiol Endocrinol Metab 295:E92–E102CrossRefPubMed
34.
Zurück zum Zitat Maizel J, Six I, Slama M et al (2009) Mechanisms of aortic and cardiac dysfunction in uremic mice with aortic calcification. Circulation 119:306–313CrossRefPubMed Maizel J, Six I, Slama M et al (2009) Mechanisms of aortic and cardiac dysfunction in uremic mice with aortic calcification. Circulation 119:306–313CrossRefPubMed
35.
Zurück zum Zitat Cleary PA, Orchard TJ, Genuth S, Wong ND, Detrano R, Backlund JY, DCCT/EDIC Research Group et al (2006) The effect of intensive glycemic treatment on coronary artery calcification in type 1 diabetic participants of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study. Diabetes 55:3556–3565CrossRefPubMed Cleary PA, Orchard TJ, Genuth S, Wong ND, Detrano R, Backlund JY, DCCT/EDIC Research Group et al (2006) The effect of intensive glycemic treatment on coronary artery calcification in type 1 diabetic participants of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study. Diabetes 55:3556–3565CrossRefPubMed
36.
37.
Zurück zum Zitat Cola C, Almeida M, Li D, Romeo F, Mehta JL (2004) Regulatory role of endothelium in the expression of genes affecting arterial calcification. Bioch Biophys Res Com 320:424–427CrossRef Cola C, Almeida M, Li D, Romeo F, Mehta JL (2004) Regulatory role of endothelium in the expression of genes affecting arterial calcification. Bioch Biophys Res Com 320:424–427CrossRef
38.
Zurück zum Zitat Schiffrin EL, Lipman ML, Mann JF (2007) Chronic kidney disease: effects on the cardiovascular system. Circulation 116:85–97CrossRefPubMed Schiffrin EL, Lipman ML, Mann JF (2007) Chronic kidney disease: effects on the cardiovascular system. Circulation 116:85–97CrossRefPubMed
39.
Zurück zum Zitat Cano DA, Rulifson IC, Heiser PW et al (2007) Regulated beta-cell regeneration in the adult mouse pancreas. Diabetes 57:958–966CrossRefPubMed Cano DA, Rulifson IC, Heiser PW et al (2007) Regulated beta-cell regeneration in the adult mouse pancreas. Diabetes 57:958–966CrossRefPubMed
40.
Zurück zum Zitat Cheung L, Zervou S, Mattsson G et al (2010) c-Myc directly induces both impaired insulin secretion and loss of beta cell mass, independently of hyperglycaemia in vivo. Islets 2:1–9CrossRef Cheung L, Zervou S, Mattsson G et al (2010) c-Myc directly induces both impaired insulin secretion and loss of beta cell mass, independently of hyperglycaemia in vivo. Islets 2:1–9CrossRef
41.
Zurück zum Zitat Duan SZ, Usher MG, Mortensen RM (2008) Peroxisome proliferator-activated receptor-gamma-mediated effects in the vasculature. Circ Res 102:283–294CrossRefPubMed Duan SZ, Usher MG, Mortensen RM (2008) Peroxisome proliferator-activated receptor-gamma-mediated effects in the vasculature. Circ Res 102:283–294CrossRefPubMed
42.
Zurück zum Zitat Matsui T, Yamagashi S, Takeuchi M, Ueda S, Fukami K, Okuda S (2009) Nifedipine, a calcium channel blocker, inhibits advanced glycation end product (AGE)-elicited mesangial cell damage by suppressing AGE receptor (RAGE) expression via peroxisome proliferator-activated receptor-gamma activation. Biochem Biophys Res Commun 385:269–272CrossRefPubMed Matsui T, Yamagashi S, Takeuchi M, Ueda S, Fukami K, Okuda S (2009) Nifedipine, a calcium channel blocker, inhibits advanced glycation end product (AGE)-elicited mesangial cell damage by suppressing AGE receptor (RAGE) expression via peroxisome proliferator-activated receptor-gamma activation. Biochem Biophys Res Commun 385:269–272CrossRefPubMed
43.
Zurück zum Zitat Schnabel R, Dupuis J, Larson MG et al (2009) Clinical and genetic factors associated with lipoprotein-associated phospholipase A2 in the Framingham Heart Study. Atherosclerosis 204:601–607CrossRefPubMed Schnabel R, Dupuis J, Larson MG et al (2009) Clinical and genetic factors associated with lipoprotein-associated phospholipase A2 in the Framingham Heart Study. Atherosclerosis 204:601–607CrossRefPubMed
44.
Zurück zum Zitat Strang AC, Hovingh GK, Stroes ES (2009) Kastelein JJ (2009) The genetics of high-density lipoprotein metabolism: clinical relevance for therapeutic approaches. Am J Cardiol 104:22E–31ECrossRefPubMed Strang AC, Hovingh GK, Stroes ES (2009) Kastelein JJ (2009) The genetics of high-density lipoprotein metabolism: clinical relevance for therapeutic approaches. Am J Cardiol 104:22E–31ECrossRefPubMed
45.
Zurück zum Zitat Corgnali M, Piconi L, Ihnat M, Ceriello A (2007) Evaluation of gliclazide ability to attenuate the hyperglycaemic 'memory' induced by high glucose in isolated human endothelial cells. Diab Metab Res Rev 24:301–309CrossRef Corgnali M, Piconi L, Ihnat M, Ceriello A (2007) Evaluation of gliclazide ability to attenuate the hyperglycaemic 'memory' induced by high glucose in isolated human endothelial cells. Diab Metab Res Rev 24:301–309CrossRef
46.
Zurück zum Zitat El-Osta A, Brasacchio D, Yao D et al (2008) Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycaemia. J Exp Med 205:2409–2417CrossRefPubMed El-Osta A, Brasacchio D, Yao D et al (2008) Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycaemia. J Exp Med 205:2409–2417CrossRefPubMed
47.
Zurück zum Zitat Nathan DM, Buse JB, Davidson MB et al (2006) Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia 49:1711–1721CrossRefPubMed Nathan DM, Buse JB, Davidson MB et al (2006) Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia 49:1711–1721CrossRefPubMed
48.
Zurück zum Zitat National Collaboration Centre for Chronic Conditions (2008) Type 2 diabetes: national clinical guideline for management in primary and secondary care (update). Royal College of Physicians, London National Collaboration Centre for Chronic Conditions (2008) Type 2 diabetes: national clinical guideline for management in primary and secondary care (update). Royal College of Physicians, London
49.
Zurück zum Zitat Ihnat MA, Thorpe JE, Kamat CD et al (2007) Reactive oxygen species mediate a cellular ‘memory’ of high glucose stress signalling. Diabetologia 50:1523–1531CrossRefPubMed Ihnat MA, Thorpe JE, Kamat CD et al (2007) Reactive oxygen species mediate a cellular ‘memory’ of high glucose stress signalling. Diabetologia 50:1523–1531CrossRefPubMed
50.
Zurück zum Zitat Ceriello A, Esposito K, Piconi L et al (2008) Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients. Diabetes 57:1349–1354CrossRefPubMed Ceriello A, Esposito K, Piconi L et al (2008) Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients. Diabetes 57:1349–1354CrossRefPubMed
Metadaten
Titel
Short-term hyperglycaemia causes non-reversible changes in arterial gene expression in a fully ‘switchable’ in vivo mouse model of diabetes
verfasst von
S. Zervou
Y.-F. Wang
A. Laiho
A. Gyenesei
L. Kytömäki
R. Hermann
S. Abouna
D. Epstein
S. Pelengaris
M. Khan
Publikationsdatum
01.12.2010
Verlag
Springer-Verlag
Erschienen in
Diabetologia / Ausgabe 12/2010
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-010-1887-5

Weitere Artikel der Ausgabe 12/2010

Diabetologia 12/2010 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.